MiniMed Group (MMED) director Mauri Laura files initial Form 3

Rhea-AI Filing Summary

MiniMed Group, Inc. director Mauri Laura has filed an initial insider ownership report on Form 3 for shares of MMED. The filing lists Mauri as a director and reports no insider stock transactions or derivative positions in the data provided.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mauri Laura

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does MiniMed Group (MMED) director Mauri Laura's Form 3 show?

The Form 3 shows that Mauri Laura is a director of MiniMed Group, Inc.. In the data provided, it reports no insider stock transactions or derivative positions for this initial filing.

Does the MMED Form 3 for Mauri Laura report any stock purchases or sales?

No transactions are reported in this Form 3 for Mauri Laura. The transaction summary shows zero buys, zero sells, and no derivative exercises or other insider trades in the provided data.

What insider roles are disclosed for Mauri Laura at MiniMed Group (MMED)?

The Form 3 discloses that Mauri Laura is a director of MiniMed Group, Inc.. The filing does not list her as an officer or a ten percent owner in the structured data provided.

Are there any derivative securities reported for Mauri Laura on MMED's Form 3?

No derivative securities are shown for Mauri Laura in this Form 3. The derivative summary is empty and the transaction summary indicates no derivative transactions or holdings in the provided information.

Does the MiniMed Group (MMED) Form 3 include any 10b5-1 trading plan details?

The Form 3 data provided includes an empty footnote entry and no reference to any Rule 10b5-1 trading plan. There are no indications of pre-arranged trading arrangements in the structured information given.